While some believe the argument that tumor cells have more Hsp90 and are also more sensitive to inhibitors than normal cells (which sounds contradictory to begin with), it would be hard to imagine that a tumor-damaging dose of an inhibitor could spare the Hsp90-negative human organs such eye, pancreas, and heart. The gene discussed is HSP90AB1; the disease is neoplasm.